Jazz Pharmaceuticals Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.38%177.610.7%$1394.84m
MRKMerck & Co., Inc. 0.44%92.290.7%$1221.16m
PFEPfizer Inc. 0.75%51.040.9%$1186.08m
LLYEli Lilly & Co. 1.70%323.021.1%$1109.83m
BMYBristol-Myers Squibb Co. -0.46%78.341.0%$1098.80m
ABBVAbbVie, Inc. 1.68%155.051.9%$1005.47m
AZNAstraZeneca Plc 2.03%67.271.0%$455.85m
SGENSeagen Inc. 0.77%179.845.7%$330.14m
TPTXTurning Point Therapeutics, Inc. 0.13%75.160.0%$296.29m
GSKGSK Plc 1.12%43.840.2%$288.25m
HZNPHorizon Therapeutics Plc -0.27%81.475.4%$176.16m
NVSNovartis AG 0.96%84.980.2%$167.92m
MRTXMirati Therapeutics, Inc. -2.07%67.091.6%$159.40m
NVONovo Nordisk A/S 1.88%110.340.1%$148.28m
ALNYAlnylam Pharmaceuticals, Inc. 1.39%144.188.1%$143.86m

Company Profile

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: Xyrem, Xywav, Sunosi, Erwinaze, Vyxeos, Defitelio, and Zepzelca. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.